PET staging improves survival of patients with lung cancer

06/27/2013 | AuntMinnie.com (free registration)

Pretreatment PET staging of limited-stage small-cell lung cancer can improve patient survival, according to a study published in the Journal of Thoracic Oncology. PET-staged patients demonstrated three-year overall survival of 47%, while those who were not staged with PET had 19% survival, the study said. Median survival after diagnosis among PET-staged patients was 32 months, while it was 17 months for patients not staged with PET.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL